Driving Growth, Innovation & Transformation with AI Quantum MRI Cancer Diagnostics
Standard clinical MRI provides exquisite anatomical resolution, but it remains fundamentally blind to cellular biochemistry. By the time a malignant tumor produces detectable anatomical changes or structural growth, cancer treatment options are often severely constrained. Quantum hyperpolarization technology overcomes this limit by boosting MRI signal sensitivity by more than 10,000 times, enabling clinicians to observe real-time cancer metabolism via carbon-13 (13C) hyperpolarized pyruvate. Blueflame Labs is the specialized AI and signal processing engineering partner turning quantum imaging into clinical reality.
We build deep learning k-space reconstruction algorithms designed specifically for low-signal, non-proton metabolic MRI. Because hyperpolarized magnetization decays rapidly within tens of seconds due to T1 relaxation, image acquisition must be blistering fast. Our physics-informed neural networks reconstruct high-resolution 3D metabolic maps from sparse, sub-sampled k-space trajectories with zero motion blur or artifact distortion.
We solve the challenge of quantifying cellular metabolic kinetics. Our AI models perform dynamic spectral unmixing, separating pyruvate, lactate, and alanine chemical shift peaks in real time, computing pixel-by-pixel metabolic conversion rates (kPL) that reveal tumor aggressiveness within minutes of patient injection.
Clinical safety, regulatory validation, and clinical software standards underpin our engineering. We adhere strictly to FDA Software as a Medical Device (SaMD), IEC 62304, and ISO 13485 standards, implementing deterministic validation suites and explainable AI architectures that radiologist teams can trust.
Seamless integration into hospital environments is guaranteed. We build certified DICOM communication gateways that transmit reconstructed metabolic overlays directly into hospital PACS (Picture Archiving and Communication Systems), allowing oncologists to review metabolic and anatomical scans side-by-side.
Partnering with Blueflame Labs enables medical imaging pioneers to accelerate clinical trials, achieve regulatory milestones, and deliver life-saving early cancer metabolic detection to clinicians worldwide.
